Roivant Sciences's total assets for Q4 2024 were $5.44B, a decrease of -6.14% from the previous quarter. ROIV total liabilities were $249.74M for the fiscal quarter, a -2.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.